Telix Pharmaceuticals Financial Overview
Telix Pharmaceuticals's market cap is currently $4.01B. The company's EPS TTM is AU$0.015079658300000002; its P/E ratio is 239.16; Telix Pharmaceuticals is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is AU$0.08. See an overview of income statement, balance sheet, and cash flow financials.
